Psychological Services Of St. Augustine Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1100 S Ponce De Leon Blvd Ste 1, St Augustine, FL 32084 Phone: 904-824-7733 |
Dr. Janet R. Mullins, Psychologist, Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24 Cathedral Pl Ste 407, St Augustine, FL 32084 Phone: 904-540-5523 |
Nicolle M Bauer Lmhc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2200 N Ponce De Leon Blvd, Ste 3, St Augustine, FL 32084 Phone: 904-501-8270 Fax: 904-819-5330 |
Safe Harbor Counseling, Inc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2692 Us Highway I, South, Suite 205, St Augustine, FL 32086 Phone: 904-669-5908 Fax: 904-794-4225 |
News Archive
Minnesota budget officials estimate it could cost the state as much as $40 million to run its health insurance exchange in 2015. The state-based online insurance marketplaces are a cornerstone of the federal health care overhaul.
Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that final data from a Phase 2 clinical trial of trabodenoson, also known as INO-8875, in patients with primary open-angle glaucoma or ocular hypertension will be presented at the Ophthalmology Innovation Summit on Thursday, November 8, 2012 at the Chicago Marriott Downtown Magnificent Mile in Chicago, IL.
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge especially in the case of small tumor nests or remaining tumor borders after the primary tumor excision.
Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers.
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
› Verified 6 days ago